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Abstract
Objective Our objective was to develop a value set based on Irish utility values for the EuroQol 5-Dimension, 5-Level 
instrument (EQ-5D-5L).
Methods The research design and data collection followed a protocol developed by the EuroQol Group. The EuroQol Valua-
tion Technology (EQ-VT) software was administered using computer-assisted personal interviews to a representative sample 
of adults resident in Ireland between 2015 and 2016. Utility values were elicited using two stated-preference techniques: 
time trade-off (TTO) and discrete-choice experiment (DCE). Each respondent completed a valuation exercise in which the 
EQ-VT system randomly selected one block of ten TTO questions from ten blocks relating to a possible 86 health states. 
One block of seven DCE pairs from 28 blocks of a possible 196 pairs of health states were randomly selected to accompany 
this. The relationship between utility values and health states was analysed using a hybrid regression model that combined 
data from the TTO and DCE techniques and expressed these as a function of the health state presented to the individual. 
This model estimated coefficients for 20 dummy variables that characterised each health state in the EQ-5D-5L framework, 
with the lowest level of severity providing the reference category in each domain. The relationship between weighted and 
unweighted TTO and DCE analyses of main effects was analysed separately.
Results Comparison of weighted and unweighted models revealed no substantive differences in results with respect to 
either DCE or TTO models. The unweighted hybrid model produced estimated effects, the ordering of which was intuitively 
consistent within each domain: lower levels of health were associated with lower utility values. Differences were evident 
between domains with respect to valuations; the disutility associated with conditions related to anxiety/depression and pain/
discomfort was higher than for other domains. The decrement in utility associated with movement from the highest to the 
lowest level of health was 0.344 for mobility, 0.287 for self-care, 0.187 for usual activities, 0.510 for pain/discomfort and 
0.646 for anxiety/depression.
Discussion The results present the first value set based on the EQ-5D-5L framework for a representative sample of residents 
in Ireland. The set reveals a higher decrement in utility associated with anxiety/depression than with other domains of health. 
Caution is warranted in comparisons with other value sets. That said, those in England, the Netherlands, Uruguay and China 
reveal that, whereas Irish values are broadly consistent with respect to mobility, self-care and usual activities, residents of 
Ireland attach a higher decrement to pain/discomfort and anxiety/depression than do other populations.
Key Points for Decision Makers 
This paper reports a EuroQol 5-Dimension, 5-Level 
instrument (EQ-5D-5L) value set for Ireland based on 
the utility values of residents in 2015–2016.
These results are useful to those evaluating new health-
care technologies in Ireland and can inform the measure-
ment of patient-reported outcomes more generally.
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s4027 3-018-0690-x) contains 
supplementary material, which is available to authorized users.
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1 Introduction
Cost-effectiveness analysis (including cost-utility analysis 
[CUA]) involves the comparative analysis of alternative uses 
of healthcare resources in terms of both their cost and their 
consequences. Interest in this analysis has grown as health-
care budgets have come under increasing pressure and the 
importance of ensuring and demonstrating value for money 
in healthcare resources has risen. Because CUA permits very 
different uses of resources to be compared in terms of value 
for money, it is recommended as an evaluation technique in 
guidance offered in many jurisdictions, including Ireland [1] 
and the UK [2]. Indeed, quality-adjusted life-years (QALYs) 
now inform the allocation of significant amounts of health-
care resource in several countries [3, 4].
The generation of QALYs requires (1) an instrument that 
measures patients’ health states and (2) a means of assign-
ing weights to those states in a manner that reflects utility 
values. The EuroQol 5-Dimension instrument (EQ-5D) is 
the preferred generic measure in the UK [2] and is widely 
used in other countries. It measures health-related quality of 
life on five dimensions: mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression. In the five-level ver-
sion of the instrument (EQ-5D-5L), 3125  (55) unique health 
states can be described, with each dimension categorized on 
five levels of severity: no problems, slight problems, moder-
ate problems, severe problems and extreme problems/unable 
to [5]. The EQ-5D-5L instrument has been shown to have 
superior discriminatory power and reduced ceiling effects 
relative to the three-level version (EQ-5D-3L) [6–10]. More-
over, unlike the EQ-5D-3L instrument, an internationally 
agreed protocol exists for the generation of utility weights 
for the EQ-5D-5L [11]. Together with the quality-control 
procedure developed alongside the valuation protocol [11], 
and the support provided for data collection by the EuroQol 
Research Foundation in the conduct of national five-level 
studies, greater supports now exist to assure the consistency 
and robustness of EQ-5D-5L value sets relative to three-level 
versions. These developments have seen the emergence of 
EQ-5D-5L national value sets in England [12], Canada [13], 
Korea [14], Indonesia [15], the Netherlands [16], Uruguay 
[17], Spain [18], Hong-Kong [19], China [20] and Germany 
[21]. Despite the reticence of the UK National Institute for 
Health and Clinical Excellence (NICE) to support the adop-
tion of the five-level version of the instrument while further 
research is undertaken [22], these instruments have permit-
ted the comparative analysis of national value sets and the 
generation of cross-walk algorithms for some countries [23].
In Ireland, the importance of health technology assess-
ment has been embraced for some time. National bodies 
such as the National Centre for Pharmacoeconomics and 
the Health Information and Quality Authority are involved in 
economic evaluations, and the latter publishes guidance on 
the conduct of evaluations in Ireland [1]. Despite this, at the 
time of writing, no national value set for the generation of 
utility weights has been published in Ireland. In this paper, 
we present the methods and results for an Irish EQ-5D-5L 
value set.
2  Methods
2.1  Design
The research design and data collection followed version 
2 of the EQ-5D-5L valuation protocol developed by the 
EuroQol Group [11, 24] and deployed the EuroQol Valua-
tion Technology (EQ-VT), developed specifically for valu-
ing EQ-5D-5L health states administered using computer-
assisted personal interviews. This version of the protocol has 
been deployed previously in Indonesia [15] and Germany 
[21]. Utility values were elicited using two stated-preference 
techniques—composite time trade-off (cTTO) and discrete-
choice experiment (DCE)—each providing distinct but com-
plementary preference data. Each respondent completed a 
valuation exercise in which the EQ-VT system randomly 
selected one block of ten cTTO tasks from ten blocks relat-
ing to a possible 86 health states and one block of seven 
DCE pairs from 28 blocks of a possible 196 pairs of health 
states. Values with respect to cTTO tasks were elicited 
using an iterative procedure. The cTTO approach combined 
conventional TTO for health states considered better than 
dead and lead-time TTO for health states that were consid-
ered worse than dead by the participant [25]. The cTTO has 
been used in a number of recently published valuation stud-
ies [15, 21] and shown to have face validity [25]. Following 
the conduct of the cTTO tasks, a ‘feedback module’ was 
conducted in which the participant was shown the ranking of 
the ten health states based on his/her cTTO values and given 
the opportunity to point out any or all responses where they 
were not satisfied with its relative ranking [26]. This was in 
turn followed by three debriefing questions regarding how 
difficult the participant found the cTTO section. A free-text 
box allowed the participant to make any further comments. 
Sociodemographic data, including the respondent’s age, sex, 
education, income and marital status, were collected along-
side utility data.
2.2  Sample
Consistent with Oppe and van Hout [27], a representa-
tive sample of at least 1000 respondent utility values were 
required for analysis. A representative sample of Irish resi-
dents was drawn using a two-stage stratified clustering pro-
cess as detailed by Haase and Pratschke [28]. In the first 
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stage, a sample of 54 small areas stratified by income and 
urban/rural classifications were drawn at random from across 
the country. In the second stage, within each small area, a 
sample of approximately 20 houses were selected at random. 
Random selection was achieved by using a random starting 
point and inviting a resident from every third house to par-
ticipate in the survey. To achieve this, each house was visited 
up to three times throughout the day and early evening in an 
effort to contact the householder. Where no response was 
elicited from the selected house, it was replaced from among 
those in the immediate vicinity, generally based on immedi-
ate physical proximity. Within each house, any adult capable 
of giving informed consent could volunteer to complete the 
survey, one volunteer per household being chosen at random.
Interviews were conducted by one of a seven-person team 
of trained surveyors. The interviewer team comprised three 
males and four females. Each surveyor was trained prior 
to deployment; training included the conduct of test inter-
views to ensure the surveyor was competent using the survey 
instrument. The quality-control process developed by the 
EuroQol Group was strictly followed, including a commit-
ment to remove batches of observations collected by inter-
viewers who were not compliant with data quality require-
ments and retrain those interviewers. The survey team met 
at the end of each week to share their experiences and ensure 
any issues encountered were dealt with consistently. Ethical 
approval for the study was granted by NUI Galway Ethics 
Committee (application number 15/JAN/04).
2.3  Analyses
Analyses proceeded in stages. First, we estimated our 
response rate and compared this across areas with different 
deprivation and urban/rural statuses. Second, descriptive 
statistics were calculated that compared the recruited sam-
ple with that of the population based on estimates from the 
Central Statistics Office for Ireland (CSO). In principle, it is 
possible to address under/over-representation of particular 
groups by re-weighting a sample. To optimise use of avail-
able utility data, both TTO and DCE, a hybrid regression 
model [29] was estimated where an adjustment was made 
to account for the censored nature of the data (TTO data 
were censored at − 1). In essence, the hybrid model [29] 
maximizes a likelihood function that is the product of the 
likelihood of combinations of continuous response data from 
the TTO and DCE responses. Instances where the respond-
ent expressed uncertainty as to the valuation they had given 
in the feedback module (which occurred in 2% of values) 
were removed in a manner consistent with that adopted in 
the German [21] and Indonesian [15] value sets. Similarly, 
in the interests of improved fit, we used the hetcont() option 
of the hyreg command as suggested by Ramos-Goñi et al. 
[29] to correct for heteroscedasticity. The estimated model 
comprised four dummy variables for each level of health 
in respect of each domain, (20 dummy variables in all), 
with the lowest level (no problems) providing the reference 
category.
Consistent with Solon et  al. [30], weighted and 
unweighted results were estimated and compared to ascer-
tain whether results were materially affected by weight-
ing. As software did not support the direct estimation of 
weighted results in the hybrid model, weighted (by age and 
sex) and unweighted versions of the TTO and DCE models 
were separately estimated and compared (see the Electronic 
Supplementary Material [ESM]). In further confirmatory 
analyses (results available in the ESM), a ‘boosted’ sample 
was generated in which respondents from under-represented 
age and sex groups were selected with replacement at ran-
dom and used to augment the existing sample. The numbers 
were drawn to ensure the sample more closely reflected the 
CSO estimates in terms of age and sex composition. A main 
effects hybrid model was estimated on this boosted sample. 
Finally, a sample in which those from over-represented age 
and sex groups were again de-selected at random until a 
sample composition better reflecting that of the CSO esti-
mates was generated (results are available in the ESM). A 
comparison of the performance of TTO and hybrid models 
based on their relative likelihoods is not meaningful [31] 
because the likelihood of the hybrid always exceeds that of 
the TTO; therefore, this avenue of investigation was not pur-
sued. Fuller details of the methods are provided in the ESM.
3  Results
3.1  Sample Characteristics
In total, 1160 surveys were completed between March 
2015 and September 2016, with the survey effort expended 
equally over the 2 years but confined to the months March to 
the end of October in both years. As shown in Fig. 1, the ran-
domly selected areas where surveys were undertaken were 
distributed geographically throughout the country. Purposive 
sampling to augment the number of younger individuals and 
males in the sample was undertaken in 2016. This followed 
a comparison of the recruited sample with that of the CSO 
population estimates for age and sex nationally. Of the 1160 
completed surveys, 102 were purposive. These individuals 
were identified initially through personal contacts, including 
work associates with subsequent snowball sampling. Exclud-
ing the purposive sample and houses where the householder 
could not be contacted despite call backs, the response rate 
to the survey was 47% (which compares with 48% in Eng-
land [12], one of the few countries to have reported such a 
statistic). The response rate when households that could not 
be contacted were included in the denominator was 19% 
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(no comparable data on this were available). An analysis 
of the relationship between response rates and the level of 
deprivation in the area studied revealed no significant dif-
ferences across deprivation levels (results available in the 
ESM). Table 1 presents descriptive statistics for the sample 
alongside those from the CSO where available. Including 
the purposive sample, the sample broadly reflects the Irish 
population, albeit with some over-representation of those 
aged > 45 years and of males. Those with tertiary-level edu-
cation were over-represented, and those with only primary-
level education were under-represented, compared with the 
population at large. Our sample also has a slightly larger 
representation of those with private health insurance and 
of married individuals, although, with the latter, this may 
reflect differences in the definitions used or the readiness 
to report cohabiting in official surveys where entitlement to 
benefits might be affected. 
3.2  Values
Figure 2 shows the percentages of cTTO inconsistencies by 
type before and after the feedback module. The figures help 
demonstrate the face validity of the data; only a small per-
centage of logically inconsistent values were returned and 
that reduced further after the feedback module was admin-
istered. No interviewer required retraining in light of quality 
assessment of their interviews, nor were any interviewer’s 
data removed from the sample because of concerns about 
data quality.
Table 2 presents the results of the main effects hybrid 
model. These represent our estimated five-level value set 
for Ireland. The table also includes a worked example 
describing the valuation of a health state. A health state that 
involves slight problems with mobility (2), moderate prob-
lems with self-care (3), slight problems with usual activities 
(2), severe pain/discomfort (4) and moderate anxiety/depres-
sion (3) involves the deduction of 0.063, 0.088, 0.049, 0.373 
and 0.202 from 1 (perfect health). In separate analyses of 
TTO and DCE data, the constant was not significant, and 
data were therefore merged without the constant. As can be 
seen from the model and reflected in the example, anxiety/
depression is the most heavily weighted health domain in 
Ireland. As can also be seen from Table 2, utility values 
are non-linear with respect to severity in all domains. For 
example, the decrement in health associated with a change in 
mobility, self-care, usual activities from level 3 to 4 is much 
greater than that from level 1 to 2 or from 2 to 3. (In Table 7 
in the ESM, decrements in utility relative to the next level of 
severity are reported for each domain.) Approximately 36% 
of our 3125 estimated values were negative, compared with 
35% in the Indonesian study [15] that used the same version 
of the protocol and hybrid modelling approach as deployed 
here (data for the German study were not reported).
Figure 2 shows that the survey yielded high-quality data 
with face validity and few inconsistencies (where logically 
dominant health states were associated with a lower utility 
than dominated health states) involving mild or severe states. 
Following training, no surveyor’s data were removed from 
the sample because of quality concerns. (Fuller details of 
survey quality are provided in the ESM. Respondents were 
less likely to express uncertainty regarding values involv-
ing ‘worse than death’ states—4% of ‘better than death’ 
compared with 2% of ‘worse than death’ states being high-
lighted in the feedback module). While our sample under-
represented younger men, it was broadly representative of 
the population with respect to many other characteristics, 
including marital status, education, numbers of people living 
with dependents aged < 18 years and health insurance sta-
tus. Confirmatory analyses (available in the ESM) revealed 
no statistically or non-statistically significant differences 
in results between weighted and unweighted analyses. The 
sample and the results derived from it can be taken as reflec-
tive of the population from which they were drawn. Our data 
were gathered over the course of 2 years and across seasons, 
which—while not an issue currently covered by the EuroQol 
protocol—is also potentially important in terms of quality. 
Utility value data collected over an extended time period 
Fig. 1  Small areas selected for survey work. EQ-5D-5L EuroQoL 
5-Dimension, 5-Level instrument
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Table 1  Sample descriptive 
statistics Sociodemographic Sample N = 1160 n 
(%)
General population 
of Ireland 2011 (%)
Pearson Chi p value
Marital  statusa 121.78 0.000
 Married/living as married 701 (60) 50
 Never married 271 (23) 39
 Divorced/separated 96 (8) 6
 Widowed 92 (8) 5
Sex 64.75 0.000
 Male 431 (37) 49
 Female 729 (63) 51
Location 6.77 0.009
 Urban 677 (58) 62
 Rural 483 (42) 38
Dependents aged < 18 years 3.62 0.057
 Living with dependents aged < 18 years 455 (39) 42
 Not living with dependents aged < 18 years 705 (61) 58
Age, years 99.85 0.000
 18–25 91 (8) 12
 25–34 166 (14) 22
 35–44 226 (19) 20
 45–54 233 (20) 17
 55–64 190 (16) 13
 65–74 163 (14) 9
  ≥ 75 91 (8) 7
Ethnicityb 30.15 0.000
 Irish 1033 (89) 83
 European (non-Irish) 86 (7) 12
 Other 41 (4) 5
Economic  activityc 150.61 0.000
 Employed part-time and full-time 559 (48) 50
 Unemployed 72 (6) 12
 Student 71 (6) 11
 Long-term sickness or disability 48 (4) 4
 Home duties/looking after home or family 129 (11) 9
 Retired 263 (23) 13
 Other (specify) 18 (2) 0
Educationd 145.36 0.000
 Primary 88 (8) 14
 Second level or less 429 (37) 37
 Third level 643 (55) 43
 Not stated/no formal education 0 (0) 6
Household income (€) 1131e
 0–10,000 48 (4)
 10,000–20,000 157 (14)
 20,001–30,000 175 (15)
 30,001–40,000 139 (12)
 40,001–50,000 119 (11)
 50,001–60,000 111 (10)
 60,001–75,000 123 (11)
 75,001–100,000 127 (11)
 100,001–200,000 111 (10)
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make it less susceptible to effects that might only exist at 
certain times of the year (e.g. seasonal affective disorder 
[32]) or the economic cycle [33]. This potentially adds fur-
ther validity to the data.
4  Discussion
The value set reported was consistent with intuition, that 
is, greater severity was associated with lower utility val-
ues. While the differences between levels of severity are not 
always statistically significant, the non-linear relationship 
between utility values and health states across each domain 
may simply reflect that individuals do not always perceive 
differences between levels of specific domains the same or 
perhaps even as material. Clear differences between domains 
in terms of their impact on utility are evident in our results. 
As noted, anxiety/depression had a much greater impact on 
utility than did other domains. Care is warranted in draw-
ing comparisons with other value sets, as many of these 
were undertaken using an earlier version of the protocol. 
Comparing Irish values with those in England [12], Can-
ada [13], Korea [14], the Netherlands [16], Uruguay [17], 
China [20] and Germany [21], broadly similar weights are 
evident in respect of the most severe levels of self-care, usual 
activities and mobility, though marked differences between 
each of these and Indonesia are evident [15]. By contrast, 
with respect to anxiety/depression, it is clear that Ireland 
attaches a greater importance to anxiety/depression than do 
these other countries. For the lowest level of health in this 
domain, for example, while the decrement is approximately 
0.29 in England, 0.18 in Uruguay, 0.23 in China and 0.42 
in the Netherlands, it is 0.65 in Ireland. The reason for this 
CSO Central Statistics Office for Ireland, EQ-5D-5L EuroQoL 5-Dimension, 5-Level instrument, VAS vis-
ual analogue scale
a The full population of Ireland (4,588,252) married not including living as married in CSO figures (adult 
population, 3,439,565)
b Usually resident population by place of birth and nationality = 4,525,281
c The labour force = total population age > 15  years is 3,608,662. Total employed aged > 15  years (full-
time + part-time) = 1,807,360. The sample employed also includes (full-time + part-time) employed and 
self-employed
d Total population = 3,003,490 (population aged 15 and over years and highest level of education com-
pleted)
e The number of individuals who reported their household income
Table 1  (continued) Sociodemographic Sample 
N = 1160 n 
(%)
General population 
of Ireland 2011 (%)
Pearson Chi p value
 > 200,000 21 (2)
Self-rated health using EQ-5D-5L
 11111 528 (46)
 Any other health state 632 (54)
Self-rated health using EQ-VAS
 < 80% 397 (34)
 80–89% 310 (27)
 90–99% 377 (33)
 100% 76 (7)
Fig. 2  Percentage of responses with inconsistencies. The proportion 
of respondents whose time trade-off data contain at least one incon-
sistency of any kind; the proportion of respondents with inconsisten-
cies involving the mildest health states (e.g. valued 21111 lower than 
another state that dominated 21111); and the proportion of respond-
ents with inconsistencies involving the worst health state (i.e. valued 
55555 higher than any other state). These proportions are shown both 
before and after respondents were given the opportunity to flag data 
for removal using the feedback module
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is unclear, and—as noted—some care is warranted with the 
comparison.
The assignment of greater disutility to decrements related 
to anxiety/depression than to other domains of health is of 
more than academic importance. Given the role of QALYs 
in the allocation of healthcare resources and of utility 
weights in the measurement of QALYs, underestimation of 
the importance attached to anxiety/depression could result in 
mental health failing to be accorded the appropriate priority 
in resource allocation decisions in Ireland.
More broadly, the reported value set has obvious value, 
not just for evaluation exercises but also for monitoring 
health. At the time of writing, no national value set exists 
in Ireland. Notwithstanding NICE hesitating to recommend 
use of the EQ-5D-5L value set for England, it does support 
use of the EQ-5D-5L, and the superior discriminatory power 
and reduced ceiling effects of the EQ-5D-5L as noted have 
already been demonstrated [6–10]. While research and 
debate around the merits of EQ-5D-3L and EQ-5D-5L 
weights for the UK continues, the development of an EQ-
5D-5L value set for Ireland marks an important development 
where the issues of transitioning from an Irish three-level 
version are less evident [34].
Our study has a number of limitations. While we col-
lected 1160 usable responses, which, relative to the size of 
the Irish population, represents a larger sample than in many 
valuation studies, it would have been preferable to sample 
still more small areas to provide a greater geographic spread 
of data. Similarly, while the slight under-representation of 
younger males in our sample had no substantive effect on 
Table 2  Irish value set
Dependent variable = value; base/reference category = no problems in each dimension; All estimates have p 
values < 0.001; coefficients are from the hybrid regression; the value for health state 23243 = 1 − (0.063 + 0
.088 + 0.049 + 0.373 + 0.202) = 0.225
AIC Akaike information criterion, BIC Bayesian information criterion, CI confidence interval, SE standard 
error
Independent variables of 
the model
Coefficient (SE) z p > |z| 95% CI Value for 
health state 
23243
Mobility 0.063
 Slight problems 0.063 (0.009) 6.99 0.000 0.045–0.081
 Moderate problems 0.097 (0.013) 7.39 0.000 0.071–0.122
 Severe problems 0.215 (0.013) 17.17 0.000 0.191–0.240
 Unable 0.344 (0.013) 26.79 0.000 0.319–0.369
Self-care 0.088
 Slight problems 0.055 (0.009) 6.46 0.000 0.039–0.072
 Moderate problems 0.088 (0.013) 6.96 0.000 0.063–0.113
 Severe problems 0.229 (0.013) 17.55 0.000 0.204–0.255
 Unable 0.287 (0.012) 24.26 0.000 0.264–0.310
Usual activities 0.049
 Slight problems 0.049 (0.009) 5.8 0.000 0.033–0.066
 Moderate problems 0.072 (0.012) 5.95 0.000 0.048–0.096
 Severe problems 0.154 (0.012) 12.75 0.000 0.131–0.178
 Unable 0.187 (0.012) 15.33 0.000 0.163–0.211
Pain/discomfort 0.373
 Slight 0.068 (0.008) 8.38 0.000 0.052–0.084
 Moderate 0.093 (0.013) 7.32 0.000 0.068–0.118
 Severe 0.373 (0.013) 28.5 0.000 0.347–0.399
 Extreme 0.510 (0.014) 36.81 0.000 0.483–0.537
Anxiety/depression 0.202
 Slight 0.080 (0.008) 9.55 0.000 0.064–0.097
 Moderate 0.202 (0.012) 16.38 0.000 0.178–0.226
 Severe 0.535 (0.013) 42.52 0.000 0.510–0.560
 Extreme 0.646 (0.013) 48.14 0.000 0.619–0.672
Log likelihood − 14,376.57
AIC 28,837.13
BIC 29,167.57
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estimates, it would have been preferable for our sample to 
more closely reflect the population characteristics across all 
parameters. We contend that neither of these issues impacted 
adversely on the quality of the data or the subsequent results. 
Survey effort was not evenly distributed across interviewers, 
as can be seen in Fig. 1 in the ESM. However, the careful 
selection and training of surveyors, supported with weekly 
team briefings to ensure consistency in approach, as well as 
bi-weekly quality assurance updates, meant that interviewers 
met the rigorous quality assurance standards required and as 
evidenced in the ESM. Finally, while a range of qualitative 
and quantitative data on the individual and their family were 
collected alongside the utility survey and will undoubtedly 
prove useful in further analyses, it was not possible to collect 
all of the data we would have wished to help interpret our 
findings. For example, we did not collect data on medica-
tions currently used by respondents that may have impacted 
on their mood nor detailed biographical data on sensitive life 
experiences or episodes of illness that may have impacted 
on utility values. Such data have no role in the production of 
a value set and are not therefore, strictly speaking, a limita-
tion of the study. Nevertheless, such data may be useful in 
subsequent work seeking to understand Irish valuations and 
the differences among these. However, within the context 
of a lengthy and demanding survey, and given interviewee 
fatigue, a balance must inevitably be struck between the 
ideal and the possible.
5  Conclusions
This paper reports an EQ-5D-5L value set for Ireland 
based on the health-related utility values of residents in 
2015–2016. These results are useful to those evaluating 
new healthcare technologies in Ireland and can inform the 
measurement of patient-reported outcomes more generally.
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